Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations
   

EFPIA Newsletter 1 September 2022

 
 
 
   

Where innovation happens, matters

As Europe re-evaluates its pharmaceutical policy framework the challenge for the next decade(s) is not if medical innovation will happen, but where it will happen. 

Five EFPIA Board members tell us why it matters to patients, to health systems, to our research ecosystem and to our economy. Read more here....

 
 
 
 
   

News

 

EFPIA statement on the EU-Turkey WTO Case on Pharmaceuticals (1)
26 July 2022

We reiterate our position in favour of an open and rules-based trading system which best supports the resilience and... Read more

 
 
 
   

Blogs

 

We won't rest until lung cancer patients can achieve the best possible outcomes
01 August 2022

The introduction of targeted treatments and immunotherapies – which have rapidly become the standard of care – are contributing... Read more

 
 
 
   

Events

 

FH Paediatric Screening Moving Prevention From Evidence to Action
06 September 2022 (Hybrid event)

Overcoming the Barriers to Implementation Read more

From unmet medical needs to solutions
21 September 2022 (The Square, Brussels)

After three years, we look forward to seeing you there! Read more

Reducing health inequalities: cancer care as a blueprint
27 September 2022 (European Health Forum Gastein (EHFG))

Organised by the EFPIA Oncology Platform, European Cancer Organisation & European Cancer Patient Coalition Read more

EU HEALTH SUMMIT 2022: TOWARDS AN EU HEALTH UNION
15 November 2022 (Brussels)

An EU Health Coalition event Read more

 
 
 
   

We published

 

EFPIA Position on Transparency of Patient Evidence in Regulatory Decision Making and Product...
24 May 2022 (Publications)

... Read more